Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab
Clinical trial NCT04770376 · UNKNOWN
Trial details
- NCT number
- NCT04770376
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-12
- Primary completion
- 2023-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.